Clinical Management of Heparin-Induced Thrombocytopenia
Diagnosis and Assessment
- A positive 4T score requires immediate discontinuation of all heparin products and initiation of a non-heparin anticoagulant, with laboratory confirmation using anti-PF4 antibody testing to guide further management, as recommended by the American Society of Hematology 1
- The 4T score is a validated clinical prediction rule used to assess the probability of Heparin-Induced Thrombocytopenia (HIT) based on four key criteria: thrombocytopenia, timing, thrombosis, and other causes of thrombocytopenia, with a total score determining the pretest probability of HIT 2
- The total score determines the pretest probability of HIT: low probability (≤3 points), intermediate probability (4-5 points), and high probability (6-8 points) 7
Management Algorithm
- For intermediate/high probability score (≥4), immediately discontinue all forms of heparin and initiate non-heparin anticoagulant therapy, with consideration of prophylactic-intensity or therapeutic-intensity anticoagulation based on bleeding risk, as recommended by the American College of Chest Physicians 1
- Order anti-PF4 antibody testing as soon as possible, and consider functional assay if immunoassay is positive, to confirm the diagnosis of HIT 3
- Screen for thrombosis with appropriate imaging, and monitor platelet count recovery after heparin discontinuation, to assess the risk of thrombotic complications 6
Special Considerations
- In cardiac surgery patients, the standard 4T score may be less reliable, and a "biphasic" pattern of platelet count decline may be more indicative of HIT, requiring alternative scoring systems or focus on platelet count trends 3
- In ICU patients, 4T scoring can be challenging due to multiple comorbidities and medications, and a lower threshold for laboratory testing may be appropriate, to reduce the risk of overdiagnosis or underdiagnosis of HIT 3
Mortality and Morbidity Implications
- Untreated HIT carries a 5-10% mortality risk, primarily from thrombotic complications, with 17-55% of untreated patients developing venous thrombosis, and 3-10% developing arterial thrombotic events, including limb artery thrombosis, stroke, and myocardial infarction 5
- Rare but serious complications of HIT include venous limb gangrene, skin necrosis, and adrenal hemorrhagic necrosis, highlighting the importance of prompt diagnosis and treatment 5